SRZN (STOCKS)
Surrozen, Inc. Common
$23.730000
-0.460000 (-1.90%)
Prev close: $24.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Craig C. Parker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $309.77M
- Employees
- 41
- P/E (TTM)
- -0.54
- P/B (TTM)
- -1.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.41 | $-1.31 | +0.9038 | +68.79% |
|
Mar 2026 (Q1)
|
$-11.65 | $-1.11 | -10.5362 | -945.97% |
|
Dec 2025 (Q4)
|
$-14.03 | $-1.21 | -12.8196 | -1,059.12% |
|
Sep 2025 (Q3)
|
$-8.36 | $-1.16 | -7.2023 | -622.12% |
Financial Statements
| Revenues | $11.51M |
| Benefits Costs and Expenses | $343.64M |
| Costs And Expenses | $343.64M |
| Operating Expenses | $55.86M |
| Depreciation and Amortization | $222.00K |
| Research and Development | $34.58M |
| Other Operating Expenses | $21.17M |
| Operating Income/Loss | -$44.35M |
| Income/Loss From Continuing Operations After Tax | -$332.13M |
| Income/Loss From Continuing Operations Before Tax | -$332.13M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$332.13M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$332.13M |
| Net Income/Loss Available To Common Stockholders, Basic | -$332.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$41.14 |
| Diluted Earnings Per Share | -$44.30 |
| Basic Average Shares | 11,683,067 |
| Diluted Average Shares | 23,166,067 |
| Assets | $115.61M |
| Current Assets | $109.40M |
| Noncurrent Assets | $6.21M |
| Fixed Assets | $456.00K |
| Other Non-current Assets | $5.75M |
| Liabilities | $334.27M |
| Current Liabilities | $9.01M |
| Accounts Payable | $1.07M |
| Other Current Liabilities | $7.94M |
| Noncurrent Liabilities | $325.26M |
| Equity | -$218.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$218.67M |
| Liabilities And Equity | $115.61M |
| Net Cash Flow From Operating Activities | -$34.76M |
| Net Cash Flow From Operating Activities, Continuing | -$34.76M |
| Net Cash Flow From Investing Activities | -$222.00K |
| Net Cash Flow From Investing Activities, Continuing | -$222.00K |
| Net Cash Flow From Financing Activities | $46.58M |
| Net Cash Flow From Financing Activities, Continuing | $46.58M |
| Net Cash Flow | $11.60M |
| Net Cash Flow, Continuing | $11.60M |
| Comprehensive Income/Loss | -$332.13M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$332.13M |
| Other Comprehensive Income/Loss | $0.00 |